Disparities in Genetic Testing for Inborn Errors of Immunity. [PDF]
Gilbert KM +3 more
europepmc +1 more source
Risk Factors for Secondary Immunodeficiency in the Aged. [PDF]
Lang A +4 more
europepmc +1 more source
Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC. [PDF]
Rayes A +52 more
europepmc +1 more source
Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study. [PDF]
Brumm VL +36 more
europepmc +1 more source
Deep Generative AI for Multi-Target Therapeutic Design: Toward Self-Improving Drug Discovery Framework. [PDF]
Kang SI, Shin JH, Wu BM, Choi HS.
europepmc +1 more source
Editorial: Rising stars in hematopoiesis and stem cells 2023. [PDF]
Muench MO, Gudmundsson KO.
europepmc +1 more source
SNAC-Tag Integration Into NPN Platform Facilitates Efficient Purification of Recombinant Proteins From Nicotiana benthamiana. [PDF]
Meng HX +6 more
europepmc +1 more source
Cellulase Production in Transgenic Plants: Molecular Pharming with a Twist
openaire +1 more source
Phosphoinositide 3-kinase δ activity in patients with systemic lupus erythematosus. [PDF]
Mirfazeli ES +12 more
europepmc +1 more source
Multi-Omics Identification of Yield Limiting Factors in Molecular Pharming
Biologics, including protein-based drugs, are among the fastest growing categories of therapeutics under development today. While most biologics are made using mammalian cell systems, plant-based production systems provide a cost-effective approach to making new and similar medicines to fight disease.
openaire +1 more source

